<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3.0" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group>
<journal-title>PLoS ONE</journal-title></journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, USA</publisher-loc></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">PONE-D-14-01071</article-id>
<article-id pub-id-type="doi">10.1371/journal.pone.0102477</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biology and life sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Proteins</subject><subj-group><subject>Lipoproteins</subject><subj-group><subject>Apolipoprotein genes</subject><subject>Apolipoproteins</subject></subj-group></subj-group></subj-group></subj-group><subj-group><subject>Evolutionary biology</subject><subj-group><subject>Population genetics</subject><subj-group><subject>Genetic polymorphism</subject></subj-group></subj-group></subj-group><subj-group><subject>Genetics</subject><subj-group><subject>Human genetics</subject><subj-group><subject>Genetic association studies</subject></subj-group></subj-group></subj-group><subj-group><subject>Nutrition</subject></subj-group></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine and health sciences</subject><subj-group><subject>Clinical genetics</subject></subj-group><subj-group><subject>Oncology</subject><subj-group><subject>Cancers and neoplasms</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Physical sciences</subject><subj-group><subject>Mathematics</subject><subj-group><subject>Statistics (mathematics)</subject><subj-group><subject>Statistical methods</subject><subj-group><subject>Meta-analysis</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Research and analysis methods</subject><subj-group><subject>Research assessment</subject><subj-group><subject>Systematic reviews</subject></subj-group></subj-group><subj-group><subject>Research design</subject><subj-group><subject>Clinical research design</subject><subject>Prospective studies</subject></subj-group></subj-group></subj-group></article-categories>
<title-group>
<article-title>Apolipoprotein E Polymorphism and Colorectal Neoplasm: Results from a Meta-Analysis</article-title>
<alt-title alt-title-type="running-head">Apolipoprotein E Polymorphism and CRN</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Tian</surname><given-names>Yun</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Wang</surname><given-names>Jirong</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ye</surname><given-names>Ying</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Sun</surname><given-names>Liqun</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Fan</surname><given-names>Yingrui</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Wang</surname><given-names>Li</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Li</surname><given-names>Juan</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Wang</surname><given-names>Zhaoxia</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Wang</surname><given-names>Keming</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib>
</contrib-group>
<aff id="aff1"><label>1</label><addr-line>Department of Oncology, the Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, PR China</addr-line></aff>
<aff id="aff2"><label>2</label><addr-line>Emergency Center, Affiliated Hospital of Xuzhou Medical College, Xuzhou, Jiangsu, PR China</addr-line></aff>
<aff id="aff3"><label>3</label><addr-line>Department of Intensive Care Unit, the Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, PR China</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple"><name name-style="western"><surname>Hold</surname><given-names>Georgina L.</given-names></name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/></contrib>
</contrib-group>
<aff id="edit1"><addr-line>University of Aberdeen, United Kingdom</addr-line></aff>
<author-notes>
<corresp id="cor1">* E-mail: <email xlink:type="simple">drkemingwang@sina.cn</email></corresp>
<fn fn-type="conflict"><p>The authors have declared that no competing interests exist.</p></fn>
<fn fn-type="con"><p>Conceived and designed the experiments: YT KW. Performed the experiments: YT JW YY. Analyzed the data: YT LS YF LW. Contributed reagents/materials/analysis tools: YT JL ZW KW. Wrote the paper: YT KW.</p></fn>
</author-notes>
<pub-date pub-type="collection"><year>2014</year></pub-date>
<pub-date pub-type="epub"><day>16</day><month>7</month><year>2014</year></pub-date>
<volume>9</volume>
<issue>7</issue>
<elocation-id>e102477</elocation-id>
<history>
<date date-type="received"><day>7</day><month>3</month><year>2014</year></date>
<date date-type="accepted"><day>19</day><month>6</month><year>2014</year></date>
</history>
<permissions>
<copyright-year>2014</copyright-year>
<copyright-holder>Tian et al</copyright-holder><license xlink:type="simple"><license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions>
<abstract>
<p>To investigate the relationship of Apolipoprotein E (<italic>APOE</italic>) gene polymorphism to colorectal neoplasia (CRN), we performed a systematic review and meta-analysis. Eligible studies were identified through a systematic literature review from PubMed, EMBASE, and the Science Citation Index up to February 2014. A combined analysis was performed, followed by a subgroup analyses stratified by the study design. We used data collected from 8 prospective studies involving respectively a total of 9243 participants and 4310 CRN cases which including 438 patients with colorectal adenoma (CRA), and 3873 patients with colorectal carcinoma (CRC). The pooled data from this meta-analysis indicated there was no significant association between <italic>APOE</italic> polymorphism and CRN (ε2: P = 0.51, OR 1.04 95% CI 0.93 to 1.16; ε4: P = 0.72, OR 0.98 95% CI 0.90 to 1.07). Interestingly, subgroup analysis demonstrated there was a significant decreased risk for proximal CRN in patients with <italic>APOE</italic> ε4 (P = 0.0007, OR 0.52 95% CI 0.35 to 0.76). Data showed no significant association between <italic>APOE</italic> genotype and overall CRN. However, compared with those carry APOE ε3 alleles, persons with <italic>APOE</italic> ε4 genotype have significant decreased risk suffering from proximal CRN but not from distal CRN.</p>
</abstract>
<funding-group><funding-statement>Funding provided by the National Natural Science Foundation of China (Grant 81200263 and 81302110). The funders had no role in study design, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><page-count count="9"/></counts></article-meta>
</front>
<body><sec id="s1">
<title>Introduction</title>
<p>Colorectal neoplasm (CRN) is an epithelial polyps which resulted from abnormal proliferation of colonic epithelial cells. Colorectal adenoma (CRA) is recognized as the well-established precursors of colorectal cancer (CRC) <xref ref-type="bibr" rid="pone.0102477-Anderson1">[1]</xref>, <xref ref-type="bibr" rid="pone.0102477-Muto1">[2]</xref>, <xref ref-type="bibr" rid="pone.0102477-Stryker1">[3]</xref>. Generally, CRA can develop into CRC through an adenoma to carcinoma sequence <xref ref-type="bibr" rid="pone.0102477-Fearon1">[4]</xref>. CRC is the third most common cancer in world-wide, accounting for 8% of all cancers <xref ref-type="bibr" rid="pone.0102477-Ferlay1">[5]</xref>. For the past decades, the mortality rate of CRC has been declined because of screening colonoscopy. Despite the success of screening colonoscopy for CRC prevention, people will be benefitted by identifying additional risk factors for CRC that might facilitate novel prevention strategies.</p>
<p>Apolipoprotein E (<italic>APOE</italic>) gene polymorphism is demonstrated to be a major factor in lipid metabolism. It is recognized recently that polymorphism of gene encoding <italic>APOE</italic> to be potential risk factor for CRN <xref ref-type="bibr" rid="pone.0102477-Mrkonjic1">[6]</xref>. The human <italic>APOE</italic> gene, which produces three distinct protein isoforms: wild-type <italic>APOE</italic> E3 (112Cys/158Arg), <italic>APOE</italic> E2 (112Cys/158Cys), and <italic>APOE</italic> E4 (112Arg/158Arg), is found located on chromosome 19 <xref ref-type="bibr" rid="pone.0102477-Rall1">[7]</xref>, <xref ref-type="bibr" rid="pone.0102477-Weisgraber1">[8]</xref>. Of these three isoforms, the most seen one is <italic>APOE</italic> E3 with a frequency of approximately 70% to 80%, while each isoform of these isoforms has its unique receptor binding activity individually <xref ref-type="bibr" rid="pone.0102477-Ganan1">[9]</xref>, <xref ref-type="bibr" rid="pone.0102477-Song1">[10]</xref>. <italic>APOE</italic> is demonstrated to have the ligand for receptors of the low-density lipoprotein (LDL) receptor family. In addition, <italic>APOE</italic> plays an important role in the synthesis of very low-density lipoprotein (VLDL) and the process of the VLDL remnants hydrolysis <xref ref-type="bibr" rid="pone.0102477-JofreMonseny1">[11]</xref>. Accumulated data indicated persons with the E2 allele presented defective receptor-binding ability, had lower plasma cholesterol levels and higher triglyceride levels. However, people with the E4 allele were found have a higher serum level of cholesterol <xref ref-type="bibr" rid="pone.0102477-Davignon1">[12]</xref>, <xref ref-type="bibr" rid="pone.0102477-Xhignesse1">[13]</xref>. Furthermore, <italic>APOE</italic> ε4 has been implicated in coronary heart disease (CHD), age-related cognitive decline, and Alzheimer’s disease <xref ref-type="bibr" rid="pone.0102477-Bretsky1">[14]</xref>, <xref ref-type="bibr" rid="pone.0102477-Corder1">[15]</xref>, <xref ref-type="bibr" rid="pone.0102477-Wilson1">[16]</xref>. It is also demonstrated by a meta-analysis that people with the ε4 allele <italic>APOE</italic> genotypes had a 42% increased risk of CHD than those with the ε3 allele <xref ref-type="bibr" rid="pone.0102477-Song1">[10]</xref>. However, the association between <italic>APOE</italic> genotype and other disease such as CRN is less clear.</p>
<p>Recent studies indicated that <italic>APOE</italic> may show its activity in CRC development by function in β-catenin localisation, tumor cell metastasis, DNA synthesis, antioxidant abilities, cell proliferation, and angiogenesis <xref ref-type="bibr" rid="pone.0102477-CedazoMinguez1">[17]</xref>, <xref ref-type="bibr" rid="pone.0102477-Grocott1">[18]</xref>, <xref ref-type="bibr" rid="pone.0102477-Niemi1">[19]</xref>, <xref ref-type="bibr" rid="pone.0102477-Vogel1">[20]</xref>. <italic>APOE</italic> also plays a major role in altering metabolism of cholesterol and bile acids, modulating angiogenesis, carcinogenic cell growth as well as metastasis <xref ref-type="bibr" rid="pone.0102477-Vogel1">[20]</xref>, <xref ref-type="bibr" rid="pone.0102477-Bayerdorffer1">[21]</xref>, <xref ref-type="bibr" rid="pone.0102477-Bayerdorffer2">[22]</xref>, <xref ref-type="bibr" rid="pone.0102477-Reddy1">[23]</xref>. Many studies have attempted to clarify the relationship of <italic>APOE</italic> polymorphism and colorectal tumor risk although the conclusions are still contradictory. A study reported that <italic>APOE</italic> E4 may be a protective factor for CRC while those with the E2 or E3 genotype had an increased risk of colon carcinoma in male <xref ref-type="bibr" rid="pone.0102477-Watson1">[24]</xref>. In addition, a study from Brazil found the ε4 genotype only presents in controls <xref ref-type="bibr" rid="pone.0102477-Souza1">[25]</xref>. A study from China found subjects with <italic>APOE</italic> ε3/ε4 genotype have lower risk suffering from CRA than those with other genotypes <xref ref-type="bibr" rid="pone.0102477-Zhongyin1">[26]</xref>. In addition, Mrkonjic et al reported no significant differences in <italic>APOE</italic> genotype frequencies were observed between CRC cases and unaffected controls <xref ref-type="bibr" rid="pone.0102477-Mrkonjic1">[6]</xref>. Furthermore, another large sample case-control study did not detect any significant associations between <italic>APOE</italic> genotype and rectal cancer <xref ref-type="bibr" rid="pone.0102477-Slattery1">[27]</xref>.</p>
<p>As the contrary conclusions of <italic>APOE</italic> gene polymorphism in CRN, for the first time, we performed a systematic review and meta-analysis focusing on the <italic>APOE</italic> genotype of possible relevance to colorectal carcinogenesis.</p>
</sec><sec id="s2" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="s2a">
<title>Search strategy</title>
<p>The published Quality of Reporting of Meta-analysis (QUOROM statement) was followed in our study <xref ref-type="bibr" rid="pone.0102477-Moher1">[28]</xref>. Electronic databases which included PubMed, EMBASE, and the Science Citation Index were searched for identification of studies on <italic>APOE</italic> polymorphisms and CRN published up to February 2014. The following search terms were used: “colorectal neoplasm”, “colorectal cancer”, “colorectal adenoma”, “polymorphisms”, “apolipoprotein E” or “<italic>Apo E</italic>” or “<italic>apoE</italic>” or “<italic>APOE</italic>”. Additionally, the reference lists of relevant publications were also screened for additional relevant studies. As a prerequisite, only those studies published in English language and focused on human subjects were identified.</p>
</sec><sec id="s2b">
<title>Inclusion criteria</title>
<p>Studies included in this meta-analysis according to following criteria: 1) evaluation of <italic>APOE</italic> polymorphism in association with CRN (including CRC and CRA); 2) study design was “cohort” or “prospective” or “follow-up” or “cross sectional” or “case–cohort” or “nested case–control”; 3) allele counts of <italic>APOE</italic> polymorphisms of cases and controls could be extracted. Studies were excluded if the data were not sufficient to perform meta-analysis. In addition, review articles or published abstracts from meeting were excluded. Furthermore, articles selected for meta-analysis had no overlap of subjects with other studies.</p>
</sec><sec id="s2c">
<title>Data extraction</title>
<p>Studies included in this meta-analysis were reviewed twice by using a standardized form for data extraction. Two authors (Y. Tian and J. Wang) independently carefully drew all the studies. Data were collected on the first author’s name, year of publication, source of control group (population based or hospital based), study design, ethnicity of patients and controls, country of origin, and numbers of <italic>APOE</italic> alleles among patients and controls. The data was extracted from each publication by a standardized protocol.</p>
</sec><sec id="s2d">
<title>Statistical analysis</title>
<p>The associations between <italic>APOE</italic> polymorphisms and CRN were evaluated by using the software Review Manager (V5.1) for windows (Oxford, England, UK). We first analyzed the risk of the ε2 and ε4 alleles compared with the wild-type ε3 allele for the development of CRN. Second, the association between <italic>APOE</italic> polymorphisms and susceptibility to CRC was estimated. Finally, we performed the meta-analysis of the relationship of the ε2 carriers and ε4 carriers and CRA risk. A statistical test for heterogeneity was performed based on the Q statistic test with a p-value less than 0.05 was considered as significant heterogeneity between studies to account for the possibility of heterogeneity across studies <xref ref-type="bibr" rid="pone.0102477-Higgins1">[29]</xref>. The data were analyzed by using both fixed effects and random effects models. The fixed-effects method by Mantel and Haenszel was used in the condition of no significant heterogeneity <xref ref-type="bibr" rid="pone.0102477-Cohn1">[30]</xref>, while the random-effects method by DerSimonian and Laird <xref ref-type="bibr" rid="pone.0102477-DerSimonian1">[31]</xref> was more appropriate when heterogeneity was present. Publication bias analysis was measured using Stata 11.0 (Stata Corp, College Station, TX) with Begg and Egger tests <xref ref-type="bibr" rid="pone.0102477-Begg1">[32]</xref>, <xref ref-type="bibr" rid="pone.0102477-Egger1">[33]</xref>.</p>
</sec></sec><sec id="s3">
<title>Results</title>
<sec id="s3a">
<title>Study characteristics</title>
<p>Seventy-two papers relevant to the words searched were retrieved (<xref ref-type="fig" rid="pone-0102477-g001">Figure 1</xref>). Through the step of screening the title, 30 duplicated articles were excluded with initial assessment. The rest 42 articles were reviewed and an additional 24 trials were excluded because of clearly not relevant, leaving 18 studies for detailed review. Of these, 10 records were excluded because they did not match the detailed criteria. At last, we identified 8 eligible studies, published from 1996 to 2009, that reported on polymorphisms of <italic>APOE</italic> and risk of CRN <xref ref-type="bibr" rid="pone.0102477-Mrkonjic1">[6]</xref>, <xref ref-type="bibr" rid="pone.0102477-Watson1">[24]</xref>, <xref ref-type="bibr" rid="pone.0102477-Souza1">[25]</xref>, <xref ref-type="bibr" rid="pone.0102477-Zhongyin1">[26]</xref>, <xref ref-type="bibr" rid="pone.0102477-Butler1">[34]</xref>, <xref ref-type="bibr" rid="pone.0102477-Kervinen1">[35]</xref>, <xref ref-type="bibr" rid="pone.0102477-Shinomiya1">[36]</xref>, <xref ref-type="bibr" rid="pone.0102477-Slattery2">[37]</xref>. Studies were carried out in Japan, Brazil, China, Australia, Finland, USA, UK and Canada. Characteristics of the studies included in the meta-analysis with <italic>APOE</italic> polymorphisms and CRN is provided through <xref ref-type="table" rid="pone-0102477-t001">Table 1</xref>. <xref ref-type="table" rid="pone-0102477-t002">Table 2</xref> showed the allele frequencies and percentage of <italic>APOE</italic> polymorphism carriers among CRN cases and controls. Appropriate genotyping methods for <italic>APOE</italic> were stated in all studies, all of which was polymerase chain reaction restriction fragment length polymorphism except 1 study <xref ref-type="bibr" rid="pone.0102477-Kervinen1">[35]</xref> using immunoblotting techniques. The deviation from Hardy–Weinberg equilibrium was assessed by the HWE program, and the results indicated that the genotype distribution of control population in most of the eight included studies were in Hardy–Weinberg equilibrium except one study <xref ref-type="bibr" rid="pone.0102477-Souza1">[25]</xref>.</p>
<fig id="pone-0102477-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0102477.g001</object-id><label>Figure 1</label><caption>
<title>Study flow diagram of search strategy.</title>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0102477.g001" position="float" xlink:type="simple"/></fig><table-wrap id="pone-0102477-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0102477.t001</object-id><label>Table 1</label><caption>
<title>Characteristics of the included studies with apolipoprotein E polymorphisms and colorectal neoplasm.</title>
</caption><alternatives><graphic id="pone-0102477-t001-1" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0102477.t001" xlink:type="simple"/>
<table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" rowspan="1" colspan="1">Author/year of publication/country</td>
<td align="left" rowspan="1" colspan="1">Enrolment</td>
<td align="left" rowspan="1" colspan="1">Case ascertainment</td>
<td align="left" rowspan="1" colspan="1">Control definition</td>
<td align="left" rowspan="1" colspan="1">Age, y, meanor range</td>
<td align="left" rowspan="1" colspan="1">Percentageof adenoma</td>
<td align="left" rowspan="1" colspan="1">Percentageof cancer</td>
<td align="left" rowspan="1" colspan="1">Colono-scopy</td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">Shinomiya/2001/Japan</td>
<td align="left" rowspan="1" colspan="1">1995–1996</td>
<td align="left" rowspan="1" colspan="1">Histologically</td>
<td align="left" rowspan="1" colspan="1">Polyp-free</td>
<td align="left" rowspan="1" colspan="1">Not reported</td>
<td align="left" rowspan="1" colspan="1">100</td>
<td align="left" rowspan="1" colspan="1">0</td>
<td align="left" rowspan="1" colspan="1">Total or partial colonoscopy</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Souza/2009/Brasil</td>
<td align="left" rowspan="1" colspan="1">2002–2003</td>
<td align="left" rowspan="1" colspan="1">Histologically</td>
<td align="left" rowspan="1" colspan="1">Neoplasia-free</td>
<td align="left" rowspan="1" colspan="1">60.6</td>
<td align="left" rowspan="1" colspan="1">0</td>
<td align="left" rowspan="1" colspan="1">100</td>
<td align="left" rowspan="1" colspan="1">Colonoscopy</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Zhongyin/2006/China</td>
<td align="left" rowspan="1" colspan="1">2003–2005</td>
<td align="left" rowspan="1" colspan="1">Histologically</td>
<td align="left" rowspan="1" colspan="1">Healthy individual</td>
<td align="left" rowspan="1" colspan="1">68.2</td>
<td align="left" rowspan="1" colspan="1">100</td>
<td align="left" rowspan="1" colspan="1">0</td>
<td align="left" rowspan="1" colspan="1">Colonoscopy</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Butler/2001/Australia</td>
<td align="left" rowspan="1" colspan="1">Not reported</td>
<td align="left" rowspan="1" colspan="1">Not reported</td>
<td align="left" rowspan="1" colspan="1">Volunteer</td>
<td align="left" rowspan="1" colspan="1">70</td>
<td align="left" rowspan="1" colspan="1">100</td>
<td align="left" rowspan="1" colspan="1">0</td>
<td align="left" rowspan="1" colspan="1">Not reported</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Kervinen/1996/Finland</td>
<td align="left" rowspan="1" colspan="1">1989–1992</td>
<td align="left" rowspan="1" colspan="1">Histologically</td>
<td align="left" rowspan="1" colspan="1">Volunteer</td>
<td align="left" rowspan="1" colspan="1">64.5</td>
<td align="left" rowspan="1" colspan="1">52.53</td>
<td align="left" rowspan="1" colspan="1">47.47</td>
<td align="left" rowspan="1" colspan="1">Total colonoscopy</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Slattery/2005/USA</td>
<td align="left" rowspan="1" colspan="1">1997–2001</td>
<td align="left" rowspan="1" colspan="1">Not reported</td>
<td align="left" rowspan="1" colspan="1">Unaffected control</td>
<td align="left" rowspan="1" colspan="1">30–79</td>
<td align="left" rowspan="1" colspan="1">0</td>
<td align="left" rowspan="1" colspan="1">100</td>
<td align="left" rowspan="1" colspan="1">Not reported</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Watson/2003/UK</td>
<td align="left" rowspan="1" colspan="1">1997–1999</td>
<td align="left" rowspan="1" colspan="1">Histologically</td>
<td align="left" rowspan="1" colspan="1">Healthy volunteer</td>
<td align="left" rowspan="1" colspan="1">55–66</td>
<td align="left" rowspan="1" colspan="1">100</td>
<td align="left" rowspan="1" colspan="1">0</td>
<td align="left" rowspan="1" colspan="1">Sigmoido-scopy</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Mrkonjic/2009/Canada</td>
<td align="left" rowspan="1" colspan="1">1997–2000</td>
<td align="left" rowspan="1" colspan="1">Histologically</td>
<td align="left" rowspan="1" colspan="1">Unaffected controls</td>
<td align="left" rowspan="1" colspan="1">20–74</td>
<td align="left" rowspan="1" colspan="1">0</td>
<td align="left" rowspan="1" colspan="1">100</td>
<td align="left" rowspan="1" colspan="1">Not reported</td>
</tr>
</tbody>
</table>
</alternatives></table-wrap><table-wrap id="pone-0102477-t002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0102477.t002</object-id><label>Table 2</label><caption>
<title>Allele frequencies and percentage of apolipoprotein E polymorphisms carriers among CRN cases and controls.</title>
</caption><alternatives><graphic id="pone-0102477-t002-2" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0102477.t002" xlink:type="simple"/>
<table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" rowspan="1" colspan="1">Study/first author</td>
<td align="left" rowspan="1" colspan="1">Ethnicity</td>
<td align="left" rowspan="1" colspan="1">Source of controls</td>
<td align="left" rowspan="1" colspan="1">Type of lesion</td>
<td colspan="4" align="left" rowspan="1">Cases</td>
<td colspan="4" align="left" rowspan="1">Controls</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">ε2</td>
<td align="left" rowspan="1" colspan="1">ε3</td>
<td align="left" rowspan="1" colspan="1">ε4</td>
<td align="left" rowspan="1" colspan="1">Total</td>
<td align="left" rowspan="1" colspan="1">ε2</td>
<td align="left" rowspan="1" colspan="1">ε3</td>
<td align="left" rowspan="1" colspan="1">ε4</td>
<td align="left" rowspan="1" colspan="1">Total</td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">Shinomiya S, et al.</td>
<td align="left" rowspan="1" colspan="1">Asians</td>
<td align="left" rowspan="1" colspan="1">Hospital</td>
<td align="left" rowspan="1" colspan="1">205 colorectal adenoma</td>
<td align="left" rowspan="1" colspan="1">18</td>
<td align="left" rowspan="1" colspan="1">296</td>
<td align="left" rowspan="1" colspan="1">44</td>
<td align="left" rowspan="1" colspan="1">358</td>
<td align="left" rowspan="1" colspan="1">25</td>
<td align="left" rowspan="1" colspan="1">357</td>
<td align="left" rowspan="1" colspan="1">58</td>
<td align="left" rowspan="1" colspan="1">440</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">69 proximal adenoma</td>
<td align="left" rowspan="1" colspan="1">9</td>
<td align="left" rowspan="1" colspan="1">113</td>
<td align="left" rowspan="1" colspan="1">7</td>
<td align="left" rowspan="1" colspan="1">129</td>
<td align="left" rowspan="1" colspan="1">25</td>
<td align="left" rowspan="1" colspan="1">357</td>
<td align="left" rowspan="1" colspan="1">58</td>
<td align="left" rowspan="1" colspan="1">440</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">110 distal adenoma</td>
<td align="left" rowspan="1" colspan="1">9</td>
<td align="left" rowspan="1" colspan="1">183</td>
<td align="left" rowspan="1" colspan="1">37</td>
<td align="left" rowspan="1" colspan="1">229</td>
<td align="left" rowspan="1" colspan="1">25</td>
<td align="left" rowspan="1" colspan="1">357</td>
<td align="left" rowspan="1" colspan="1">58</td>
<td align="left" rowspan="1" colspan="1">440</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Souza DRS, et al.</td>
<td align="left" rowspan="1" colspan="1">Brazilian</td>
<td align="left" rowspan="1" colspan="1">Hospital</td>
<td align="left" rowspan="1" colspan="1">87 colorectal cancer</td>
<td align="left" rowspan="1" colspan="1">11</td>
<td align="left" rowspan="1" colspan="1">143</td>
<td align="left" rowspan="1" colspan="1">20</td>
<td align="left" rowspan="1" colspan="1">174</td>
<td align="left" rowspan="1" colspan="1">12</td>
<td align="left" rowspan="1" colspan="1">116</td>
<td align="left" rowspan="1" colspan="1">18</td>
<td align="left" rowspan="1" colspan="1">146</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Zhoungyin Z, et al.</td>
<td align="left" rowspan="1" colspan="1">Chinese</td>
<td align="left" rowspan="1" colspan="1">Hospital</td>
<td align="left" rowspan="1" colspan="1">98 colorectal adenoma</td>
<td align="left" rowspan="1" colspan="1">17</td>
<td align="left" rowspan="1" colspan="1">168</td>
<td align="left" rowspan="1" colspan="1">11</td>
<td align="left" rowspan="1" colspan="1">196</td>
<td align="left" rowspan="1" colspan="1">5</td>
<td align="left" rowspan="1" colspan="1">67</td>
<td align="left" rowspan="1" colspan="1">8</td>
<td align="left" rowspan="1" colspan="1">80</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Butler WJ, et al.</td>
<td align="left" rowspan="1" colspan="1">Caucasians</td>
<td align="left" rowspan="1" colspan="1">Population</td>
<td align="left" rowspan="1" colspan="1">219 colorectal cancer</td>
<td align="left" rowspan="1" colspan="1">21</td>
<td align="left" rowspan="1" colspan="1">266</td>
<td align="left" rowspan="1" colspan="1">47</td>
<td align="left" rowspan="1" colspan="1">334</td>
<td align="left" rowspan="1" colspan="1">31</td>
<td align="left" rowspan="1" colspan="1">303</td>
<td align="left" rowspan="1" colspan="1">66</td>
<td align="left" rowspan="1" colspan="1">400</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Kervinen K, et al.</td>
<td align="left" rowspan="1" colspan="1">Caucasians</td>
<td align="left" rowspan="1" colspan="1">Population</td>
<td align="left" rowspan="1" colspan="1">257 colorectal neoplasm</td>
<td align="left" rowspan="1" colspan="1">21</td>
<td align="left" rowspan="1" colspan="1">426</td>
<td align="left" rowspan="1" colspan="1">67</td>
<td align="left" rowspan="1" colspan="1">514</td>
<td align="left" rowspan="1" colspan="1">13</td>
<td align="left" rowspan="1" colspan="1">313</td>
<td align="left" rowspan="1" colspan="1">72</td>
<td align="left" rowspan="1" colspan="1">398</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">122 colorectal carcinoma</td>
<td align="left" rowspan="1" colspan="1">7</td>
<td align="left" rowspan="1" colspan="1">204</td>
<td align="left" rowspan="1" colspan="1">33</td>
<td align="left" rowspan="1" colspan="1">244</td>
<td align="left" rowspan="1" colspan="1">13</td>
<td align="left" rowspan="1" colspan="1">313</td>
<td align="left" rowspan="1" colspan="1">72</td>
<td align="left" rowspan="1" colspan="1">398</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">135 colorectal adenoma</td>
<td align="left" rowspan="1" colspan="1">14</td>
<td align="left" rowspan="1" colspan="1">202</td>
<td align="left" rowspan="1" colspan="1">34</td>
<td align="left" rowspan="1" colspan="1">758</td>
<td align="left" rowspan="1" colspan="1">13</td>
<td align="left" rowspan="1" colspan="1">313</td>
<td align="left" rowspan="1" colspan="1">72</td>
<td align="left" rowspan="1" colspan="1">398</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">81 proximal neoplasm</td>
<td align="left" rowspan="1" colspan="1">8</td>
<td align="left" rowspan="1" colspan="1">142</td>
<td align="left" rowspan="1" colspan="1">12</td>
<td align="left" rowspan="1" colspan="1">162</td>
<td align="left" rowspan="1" colspan="1">13</td>
<td align="left" rowspan="1" colspan="1">313</td>
<td align="left" rowspan="1" colspan="1">72</td>
<td align="left" rowspan="1" colspan="1">398</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">176 distal neoplasm</td>
<td align="left" rowspan="1" colspan="1">13</td>
<td align="left" rowspan="1" colspan="1">284</td>
<td align="left" rowspan="1" colspan="1">55</td>
<td align="left" rowspan="1" colspan="1">352</td>
<td align="left" rowspan="1" colspan="1">13</td>
<td align="left" rowspan="1" colspan="1">313</td>
<td align="left" rowspan="1" colspan="1">72</td>
<td align="left" rowspan="1" colspan="1">398</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Slattery ML, et al.</td>
<td align="left" rowspan="1" colspan="1">Mainly Caucasians</td>
<td align="left" rowspan="1" colspan="1">Not reported</td>
<td align="left" rowspan="1" colspan="1">2333 colorectal cancer</td>
<td align="left" rowspan="1" colspan="1">405</td>
<td align="left" rowspan="1" colspan="1">3544</td>
<td align="left" rowspan="1" colspan="1">697</td>
<td align="left" rowspan="1" colspan="1">4646</td>
<td align="left" rowspan="1" colspan="1">475</td>
<td align="left" rowspan="1" colspan="1">4534</td>
<td align="left" rowspan="1" colspan="1">845</td>
<td align="left" rowspan="1" colspan="1">5854</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">1556 colon cancer</td>
<td align="left" rowspan="1" colspan="1">272</td>
<td align="left" rowspan="1" colspan="1">2355</td>
<td align="left" rowspan="1" colspan="1">475</td>
<td align="left" rowspan="1" colspan="1">3102</td>
<td align="left" rowspan="1" colspan="1">323</td>
<td align="left" rowspan="1" colspan="1">2990</td>
<td align="left" rowspan="1" colspan="1">575</td>
<td align="left" rowspan="1" colspan="1">3888</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">777 rectal cancer</td>
<td align="left" rowspan="1" colspan="1">133</td>
<td align="left" rowspan="1" colspan="1">1189</td>
<td align="left" rowspan="1" colspan="1">222</td>
<td align="left" rowspan="1" colspan="1">1544</td>
<td align="left" rowspan="1" colspan="1">152</td>
<td align="left" rowspan="1" colspan="1">1544</td>
<td align="left" rowspan="1" colspan="1">370</td>
<td align="left" rowspan="1" colspan="1">1966</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Watson MA, et al.</td>
<td align="left" rowspan="1" colspan="1">Caucasians</td>
<td align="left" rowspan="1" colspan="1">Population</td>
<td align="left" rowspan="1" colspan="1">206 colorectal cancer</td>
<td align="left" rowspan="1" colspan="1">39</td>
<td align="left" rowspan="1" colspan="1">303</td>
<td align="left" rowspan="1" colspan="1">70</td>
<td align="left" rowspan="1" colspan="1">412</td>
<td align="left" rowspan="1" colspan="1">52</td>
<td align="left" rowspan="1" colspan="1">550</td>
<td align="left" rowspan="1" colspan="1">104</td>
<td align="left" rowspan="1" colspan="1">706</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">59 proximal adenoma</td>
<td align="left" rowspan="1" colspan="1">13</td>
<td align="left" rowspan="1" colspan="1">90</td>
<td align="left" rowspan="1" colspan="1">15</td>
<td align="left" rowspan="1" colspan="1">118</td>
<td align="left" rowspan="1" colspan="1">52</td>
<td align="left" rowspan="1" colspan="1">550</td>
<td align="left" rowspan="1" colspan="1">104</td>
<td align="left" rowspan="1" colspan="1">706</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">147 distal adenomas</td>
<td align="left" rowspan="1" colspan="1">26</td>
<td align="left" rowspan="1" colspan="1">213</td>
<td align="left" rowspan="1" colspan="1">55</td>
<td align="left" rowspan="1" colspan="1">294</td>
<td align="left" rowspan="1" colspan="1">52</td>
<td align="left" rowspan="1" colspan="1">550</td>
<td align="left" rowspan="1" colspan="1">10</td>
<td align="left" rowspan="1" colspan="1">706</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Mrkonjic M, et al.</td>
<td align="left" rowspan="1" colspan="1">Mainly Caucasians</td>
<td align="left" rowspan="1" colspan="1">Hospital</td>
<td align="left" rowspan="1" colspan="1">906 colorectal cancer</td>
<td align="left" rowspan="1" colspan="1">109</td>
<td align="left" rowspan="1" colspan="1">2757</td>
<td align="left" rowspan="1" colspan="1">206</td>
<td align="left" rowspan="1" colspan="1">3072</td>
<td align="left" rowspan="1" colspan="1">138</td>
<td align="left" rowspan="1" colspan="1">3156</td>
<td align="left" rowspan="1" colspan="1">256</td>
<td align="left" rowspan="1" colspan="1">3550</td>
</tr>
</tbody>
</table>
</alternatives></table-wrap></sec><sec id="s3b">
<title>Overall analyses on the association of <italic>APOE</italic> polymorphisms and CRN</title>
<p>The meta-analysis of the <italic>APOE</italic> alleles and the risk of CRN was performed firstly. All 8 studies were eligible for assessing the impact of at least one of <italic>APOE</italic> alleles on the CRN risk <xref ref-type="bibr" rid="pone.0102477-Mrkonjic1">[6]</xref>, <xref ref-type="bibr" rid="pone.0102477-Watson1">[24]</xref>, <xref ref-type="bibr" rid="pone.0102477-Souza1">[25]</xref>, <xref ref-type="bibr" rid="pone.0102477-Zhongyin1">[26]</xref>, <xref ref-type="bibr" rid="pone.0102477-Butler1">[34]</xref>, <xref ref-type="bibr" rid="pone.0102477-Kervinen1">[35]</xref>, <xref ref-type="bibr" rid="pone.0102477-Shinomiya1">[36]</xref>, <xref ref-type="bibr" rid="pone.0102477-Slattery2">[37]</xref>. Comparison of prevalence of the ε2 vs. ε3 alleles among cases and controls showed no statistically significant heterogeneity between studies (Q = 6.03, p = 0.54, I<sup>2</sup> = 0%, <xref ref-type="fig" rid="pone-0102477-g002">Figure 2A</xref>). The fixed-model was then used. Among the populations in the included studies, the presence of ε2 allele conferred no risk for CRN (OR, 1.04; 95% CI, 0.93 to 1.16; p = 0.51, <xref ref-type="fig" rid="pone-0102477-g002">Figure 2A</xref>). In addition, the association of ε4 carriers vs. ε3 alleles between cases and controls was estimated. Because there was no statistical heterogeneity between studies (Q = 10.52, p = 0.16, I<sup>2</sup> = 33%, <xref ref-type="fig" rid="pone-0102477-g002">Figure 2B</xref>), the fixed effects mode was applied. The pooled data indicated presence of the ε4 allele indicated no decreased risk of CRN, in comparison with the ε3 allele (OR 0.98 95% CI 0.90 to 1.07, p = 0.72; <xref ref-type="fig" rid="pone-0102477-g002">Figure 2B</xref>). Our data also showed that individuals with the ε2 had similar risk of CRN compared with those with the ε4 (OR 1.04, 95% CI 0.92 to 1.19, p = 0.52). (<xref ref-type="fig" rid="pone-0102477-g002">Figure 2</xref>). Results of genotypic models for comparisons of E2, E3 and E4 genotypes in both dominant and recessive models were presented in <xref ref-type="table" rid="pone-0102477-t003">table 3</xref>.</p>
<fig id="pone-0102477-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0102477.g002</object-id><label>Figure 2</label><caption>
<title>Odds ratio of colorectal neoplasm (CRN) (adenoma and cancer combined) with <italic>APOE</italic> polymorphism for ε2 versus ε3 (A) and ε4 versus ε3 (B).</title>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0102477.g002" position="float" xlink:type="simple"/></fig><table-wrap id="pone-0102477-t003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0102477.t003</object-id><label>Table 3</label><caption>
<title>Comparisons of apolipoprotein E genotype and CRN risk.</title>
</caption><alternatives><graphic id="pone-0102477-t003-3" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0102477.t003" xlink:type="simple"/>
<table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td colspan="2" align="left" rowspan="1">Comparisons</td>
<td align="left" rowspan="1" colspan="1">Pooled OR (95% CI)</td>
<td align="left" rowspan="1" colspan="1">P value</td>
<td align="left" rowspan="1" colspan="1">I<sup>2</sup> (%)</td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">E2 vs E3 for CRN</td>
<td align="left" rowspan="1" colspan="1">E2/2 vs E3/3</td>
<td align="left" rowspan="1" colspan="1">0.99 (0.56, 1.77)</td>
<td align="left" rowspan="1" colspan="1">0.99</td>
<td align="left" rowspan="1" colspan="1">0</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">E2/3 vs E3/3</td>
<td align="left" rowspan="1" colspan="1">1.07 (0.94, 1.22)</td>
<td align="left" rowspan="1" colspan="1">0.32</td>
<td align="left" rowspan="1" colspan="1">40</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">E2/2+E2/3 vs E3/3</td>
<td align="left" rowspan="1" colspan="1">1.07 (0.94, 1.22)</td>
<td align="left" rowspan="1" colspan="1">0.32</td>
<td align="left" rowspan="1" colspan="1">22</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">E2/2 vs E2/3+E3/3</td>
<td align="left" rowspan="1" colspan="1">1.00 (0.56, 1.77)</td>
<td align="left" rowspan="1" colspan="1">0.99</td>
<td align="left" rowspan="1" colspan="1">0</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">E4 vs E3 for CRN</td>
<td align="left" rowspan="1" colspan="1">E4/4 vs E3/3</td>
<td align="left" rowspan="1" colspan="1">0.93 (0.69, 1.26)</td>
<td align="left" rowspan="1" colspan="1">0.64</td>
<td align="left" rowspan="1" colspan="1">0</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">E4/3 vs E3/3</td>
<td align="left" rowspan="1" colspan="1">1.01 (0.91, 1.12)</td>
<td align="left" rowspan="1" colspan="1">0.90</td>
<td align="left" rowspan="1" colspan="1">41</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">E4/4+E4/3 vs E3/3</td>
<td align="left" rowspan="1" colspan="1">1.00 (0.90, 1.11)</td>
<td align="left" rowspan="1" colspan="1">0.99</td>
<td align="left" rowspan="1" colspan="1">40</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">E4/4 vs E4/3+E3/3</td>
<td align="left" rowspan="1" colspan="1">0.93 (0.69, 1.25)</td>
<td align="left" rowspan="1" colspan="1">0.62</td>
<td align="left" rowspan="1" colspan="1">0</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">E2 vs E3 for CRC</td>
<td align="left" rowspan="1" colspan="1">E2/2 vs E3/3</td>
<td align="left" rowspan="1" colspan="1">0.99 (0.55, 1.78)</td>
<td align="left" rowspan="1" colspan="1">0.97</td>
<td align="left" rowspan="1" colspan="1">0</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">E2/3 vs E3/3</td>
<td align="left" rowspan="1" colspan="1">1.07 (0.94, 1.22)</td>
<td align="left" rowspan="1" colspan="1">0.32</td>
<td align="left" rowspan="1" colspan="1">52</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">E2/2+E2/3 vs E3/3</td>
<td align="left" rowspan="1" colspan="1">1.07 (0.94, 1.22)</td>
<td align="left" rowspan="1" colspan="1">0.33</td>
<td align="left" rowspan="1" colspan="1">38</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">E2/2 vs E2/3+E3/3</td>
<td align="left" rowspan="1" colspan="1">0.99 (0.55, 1.78)</td>
<td align="left" rowspan="1" colspan="1">0.98</td>
<td align="left" rowspan="1" colspan="1">0</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">E4 vs E3 for CRC</td>
<td align="left" rowspan="1" colspan="1">E4/4 vs E3/3</td>
<td align="left" rowspan="1" colspan="1">0.93 (0.69, 1.26)</td>
<td align="left" rowspan="1" colspan="1">0.64</td>
<td align="left" rowspan="1" colspan="1">0</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">E4/3 vs E3/3</td>
<td align="left" rowspan="1" colspan="1">1.01 (0.91, 1.13)</td>
<td align="left" rowspan="1" colspan="1">0.78</td>
<td align="left" rowspan="1" colspan="1">30</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">E4/4+E4/3 vs E3/3</td>
<td align="left" rowspan="1" colspan="1">1.01 (0.91, 1.13)</td>
<td align="left" rowspan="1" colspan="1">0.78</td>
<td align="left" rowspan="1" colspan="1">30</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">E4/4 vs E4/3+E3/3</td>
<td align="left" rowspan="1" colspan="1">0.93 (0.69, 1.25)</td>
<td align="left" rowspan="1" colspan="1">0.62</td>
<td align="left" rowspan="1" colspan="1">0</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">E2 vs E3 for CRA</td>
<td align="left" rowspan="1" colspan="1">E2/2 vs E3/3</td>
<td align="left" rowspan="1" colspan="1">0.87 (0.11, 6.91)</td>
<td align="left" rowspan="1" colspan="1">0.89</td>
<td align="left" rowspan="1" colspan="1">0</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">E2/3 vs E3/3</td>
<td align="left" rowspan="1" colspan="1">1.43 (0.69, 2.97)</td>
<td align="left" rowspan="1" colspan="1">0.33</td>
<td align="left" rowspan="1" colspan="1">0</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">E2/2+E2/3 vs E3/3</td>
<td align="left" rowspan="1" colspan="1">1.42 (0.70, 2.86)</td>
<td align="left" rowspan="1" colspan="1">0.33</td>
<td align="left" rowspan="1" colspan="1">0</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">E2/2 vs E2/3+E3/3</td>
<td align="left" rowspan="1" colspan="1">0.85 (0.11, 6.76)</td>
<td align="left" rowspan="1" colspan="1">0.88</td>
<td align="left" rowspan="1" colspan="1">0</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">E4 vs E3 for CRA</td>
<td align="left" rowspan="1" colspan="1">E4/4 vs E3/3</td>
<td align="left" rowspan="1" colspan="1">0.81 (0.30, 2.18)</td>
<td align="left" rowspan="1" colspan="1">0.67</td>
<td align="left" rowspan="1" colspan="1">0</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">E4/3 vs E3/3</td>
<td align="left" rowspan="1" colspan="1">0.70 (0.50, 0.98)</td>
<td align="left" rowspan="1" colspan="1">0.04</td>
<td align="left" rowspan="1" colspan="1">0</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">E4/4+E4/3 vs E3/3</td>
<td align="left" rowspan="1" colspan="1">0.71 (0.51, 0.98)</td>
<td align="left" rowspan="1" colspan="1">0.04</td>
<td align="left" rowspan="1" colspan="1">6</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">E4/4 vs E4/3+E3/3</td>
<td align="left" rowspan="1" colspan="1">0.88 (0.32, 2.36)</td>
<td align="left" rowspan="1" colspan="1">0.79</td>
<td align="left" rowspan="1" colspan="1">0</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">E2 vs E3 for proximal CRN</td>
<td align="left" rowspan="1" colspan="1">E2/2 vs E3/3</td>
<td align="left" rowspan="1" colspan="1">0.67 (0.03, 16.67)</td>
<td align="left" rowspan="1" colspan="1">0.81</td>
<td align="left" rowspan="1" colspan="1">0</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">E2/3 vs E3/3</td>
<td align="left" rowspan="1" colspan="1">1.99 (1.08, 3.68)</td>
<td align="left" rowspan="1" colspan="1">0.03</td>
<td align="left" rowspan="1" colspan="1">0</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">E2/2+E2/3 vs E3/3</td>
<td align="left" rowspan="1" colspan="1">0.64 (0.03, 15.81)</td>
<td align="left" rowspan="1" colspan="1">0.78</td>
<td align="left" rowspan="1" colspan="1">0</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">E2/2 vs E2/3+E3/3</td>
<td align="left" rowspan="1" colspan="1">1.90 (1.03, 3.49)</td>
<td align="left" rowspan="1" colspan="1">0.04</td>
<td align="left" rowspan="1" colspan="1">0</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">E4 vs E3 for distal CRN</td>
<td align="left" rowspan="1" colspan="1">E4/4 vs E3/3</td>
<td align="left" rowspan="1" colspan="1">0.30 (0.06, 1.58)</td>
<td align="left" rowspan="1" colspan="1">0.15</td>
<td align="left" rowspan="1" colspan="1">0</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">E4/3 vs E3/3</td>
<td align="left" rowspan="1" colspan="1">0.70 (0.46, 1.07)</td>
<td align="left" rowspan="1" colspan="1">0.10</td>
<td align="left" rowspan="1" colspan="1">61</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">E4/4+E4/3 vs E3/3</td>
<td align="left" rowspan="1" colspan="1">0.64 (0.42, 0.97)</td>
<td align="left" rowspan="1" colspan="1">0.04</td>
<td align="left" rowspan="1" colspan="1">61</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">E4/4 vs E4/3+E3/3</td>
<td align="left" rowspan="1" colspan="1">0.32 (0.06, 1.73)</td>
<td align="left" rowspan="1" colspan="1">0.19</td>
<td align="left" rowspan="1" colspan="1">0</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">E2 vs E3 for distal CRN</td>
<td align="left" rowspan="1" colspan="1">E2/2 vs E3/3</td>
<td align="left" rowspan="1" colspan="1">1.08 (0.07, 17.43)</td>
<td align="left" rowspan="1" colspan="1">0.96</td>
<td align="left" rowspan="1" colspan="1">0</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">E2/3 vs E3/3</td>
<td align="left" rowspan="1" colspan="1">1.48 (0.89, 2.45)</td>
<td align="left" rowspan="1" colspan="1">0.13</td>
<td align="left" rowspan="1" colspan="1">0</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">E2/2+E2/3 vs E3/3</td>
<td align="left" rowspan="1" colspan="1">1.46 (0.89, 2.41)</td>
<td align="left" rowspan="1" colspan="1">0.13</td>
<td align="left" rowspan="1" colspan="1">0</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">E2/2 vs E2/3+E3/3</td>
<td align="left" rowspan="1" colspan="1">1.05 (0.06, 16.93)</td>
<td align="left" rowspan="1" colspan="1">0.97</td>
<td align="left" rowspan="1" colspan="1">0</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">E4 vs E3 for distal CRN</td>
<td align="left" rowspan="1" colspan="1">E4/4 vs E3/3</td>
<td align="left" rowspan="1" colspan="1">0.90 (0.66, 1.22)</td>
<td align="left" rowspan="1" colspan="1">0.49</td>
<td align="left" rowspan="1" colspan="1">82</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">E4/3 vs E3/3</td>
<td align="left" rowspan="1" colspan="1">1.44 (0.68, 3.08)</td>
<td align="left" rowspan="1" colspan="1">0.34</td>
<td align="left" rowspan="1" colspan="1">0</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">E4/4+E4/3 vs E3/3</td>
<td align="left" rowspan="1" colspan="1">0.94 (0.70, 1.27)</td>
<td align="left" rowspan="1" colspan="1">0.70</td>
<td align="left" rowspan="1" colspan="1">81</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">E4/4 vs E4/3+E3/3</td>
<td align="left" rowspan="1" colspan="1">12.01 (6.84, 21.10)</td>
<td align="left" rowspan="1" colspan="1">0.0001</td>
<td align="left" rowspan="1" colspan="1">48</td>
</tr>
</tbody>
</table>
</alternatives></table-wrap></sec><sec id="s3c">
<title>Overall analyses on the association of <italic>APOE</italic> polymorphisms and CRC</title>
<p>There were a total of 6 studies evaluating the association between <italic>APOE</italic> polymorphisms and CRC. Five studies of the ε2 vs. ε3 alleles were enrolled in this analysis <xref ref-type="bibr" rid="pone.0102477-Mrkonjic1">[6]</xref>, <xref ref-type="bibr" rid="pone.0102477-Watson1">[24]</xref>, <xref ref-type="bibr" rid="pone.0102477-Souza1">[25]</xref>, <xref ref-type="bibr" rid="pone.0102477-Butler1">[34]</xref>, <xref ref-type="bibr" rid="pone.0102477-Kervinen1">[35]</xref>, <xref ref-type="bibr" rid="pone.0102477-Slattery2">[37]</xref>. The combined results based on these 6 studies showed that, compared with those with ε2 alleles, there was no significant risk of CRC of individuals with the ε3 alleles (OR 1.03, 95% CI 0.92 to 1.16, p = 0.60, <xref ref-type="fig" rid="pone-0102477-g003">Figure 3, A</xref>). Fixed effects mode was used because there was no heterogeneity between studies (Q = 5.77, p = 0.33, I<sup>2</sup> = 13%, <xref ref-type="fig" rid="pone-0102477-g003">Figure 3, A</xref>). There were 6 studies of the ε4 vs. ε3 alleles were enrolled in this analysis <xref ref-type="bibr" rid="pone.0102477-Mrkonjic1">[6]</xref>, <xref ref-type="bibr" rid="pone.0102477-Watson1">[24]</xref>, <xref ref-type="bibr" rid="pone.0102477-Souza1">[25]</xref>, <xref ref-type="bibr" rid="pone.0102477-Butler1">[34]</xref>, <xref ref-type="bibr" rid="pone.0102477-Kervinen1">[35]</xref>, <xref ref-type="bibr" rid="pone.0102477-Slattery2">[37]</xref>. The pooled data indicated that, compared with those with ε4 alleles, there was no significant risk of CRC of individuals with the ε3 alleles (OR 1.00, 95% CI 0.92 to 1.109, p = 1.00; <xref ref-type="fig" rid="pone-0102477-g003">Figure 3, B</xref>). Fixed effects mode was used as there was no heterogeneity between studies (Q = 7.12, p = 0.21, I<sup>2</sup> = 30%, <xref ref-type="fig" rid="pone-0102477-g003">Figure 3, B</xref>). We found that, in comparison with the ε4 carriers, ε2 carriers had a similar risk for CRC development (OR 1.00, 95% CI 0.87 to 1.15, p = 1.00). <xref ref-type="table" rid="pone-0102477-t003">Table 3</xref> showed the analysis of of E2, E3 and E4 genotypes comparisons in both dominant and recessive models were presented in <xref ref-type="table" rid="pone-0102477-t003">table 3</xref>.</p>
<fig id="pone-0102477-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0102477.g003</object-id><label>Figure 3</label><caption>
<title>Forest plots of the meta-analysis of associations between alleles of <italic>APOE</italic> polymorphism and CRC (colorectal cancer) risk (A, ε2 versus ε3; B, ε4 versus ε3).</title>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0102477.g003" position="float" xlink:type="simple"/></fig></sec><sec id="s3d">
<title>Overall analyses on the association of <italic>APOE</italic> polymorphisms and CRA</title>
<p>There were a total of 3 studies of the ε2 vs. ε3 alleles for CRA were enrolled in this analysis <xref ref-type="bibr" rid="pone.0102477-Zhongyin1">[26]</xref>, <xref ref-type="bibr" rid="pone.0102477-Kervinen1">[35]</xref>, <xref ref-type="bibr" rid="pone.0102477-Shinomiya1">[36]</xref>. The combined results based on these 3 studies did not provide evidence of significant risk of CRA of individuals with the ε2 alleles when compared with those with ε3 alleles (OR 1.16, 95% CI 0.75 to 1.79, p = 0.50; <xref ref-type="fig" rid="pone-0102477-g004">Figure 4, A</xref>). Fixed effects mode was used as there was no heterogeneity between studies (Q = 1.76, p = 0.42, I<sup>2</sup> = 0%, <xref ref-type="fig" rid="pone-0102477-g004">Figure 4, A</xref>). Three studies of the ε4 vs. ε3 alleles for CRA were enrolled in this analysis <xref ref-type="bibr" rid="pone.0102477-Zhongyin1">[26]</xref>, <xref ref-type="bibr" rid="pone.0102477-Kervinen1">[35]</xref>, <xref ref-type="bibr" rid="pone.0102477-Shinomiya1">[36]</xref>. The pooled data did not support the concept that individuals with the ε4 alleles presented significant decreased risk of CRA, compared with those with ε3 alleles (OR 0.79, 95% CI 0.59 to 1.06, p = 0.12; <xref ref-type="fig" rid="pone-0102477-g004">Figure 4, B</xref>). Fixed effects mode was applied because the absence of heterogeneity between studies (Q = 1.14, p = 0.56, I<sup>2</sup> = 0%, <xref ref-type="fig" rid="pone-0102477-g004">Figure 4, B</xref>). In addition, we found there was no difference in CRA risk among individuals with the ε2 or ε4 genotypes (OR 1.48, 95% CI 0.89 to 2.45, p = 0.13). Results of genotypic models for comparisons of E2, E3 and E4 genotypes in both dominant and recessive models were indicated in <xref ref-type="table" rid="pone-0102477-t003">table 3</xref>.</p>
<fig id="pone-0102477-g004" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0102477.g004</object-id><label>Figure 4</label><caption>
<title>Forest plots of odds ratio with 95% CI for <italic>APOE</italic> polymorphism and CRA (colorectal adenoma) risk (A, ε2 versus ε3; B, ε4 versus ε3).</title>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0102477.g004" position="float" xlink:type="simple"/></fig></sec><sec id="s3e">
<title>Overall analyses on the association of <italic>APOE</italic> polymorphisms and proximal CRN</title>
<p>There were 3 studies with extractable data evaluated the association between <italic>APOE</italic> polymorphisms and proximal CRN <xref ref-type="bibr" rid="pone.0102477-Watson1">[24]</xref>, <xref ref-type="bibr" rid="pone.0102477-Kervinen1">[35]</xref>, <xref ref-type="bibr" rid="pone.0102477-Shinomiya1">[36]</xref>. Subgroup analysis based on these 3 studies showed that, compared with those with ε2 alleles, there was no significant risk of proximal CRN of individuals with the ε3 alleles (OR 1.35, 95% CI 0.87 to 2.09, p = 0.18, <xref ref-type="fig" rid="pone-0102477-g005">Figure 5, A</xref>). Fixed effects mode was used because there was no heterogeneity between studies (Q = 0.32, p = 0.85, I<sup>2</sup> = 0%, <xref ref-type="fig" rid="pone-0102477-g005">Figure 5, A</xref>). However, data from this subgroup analysis demonstrated the significant decreased risk of proximal CRN of individuals with the ε4 alleles when compared with those with ε3 alleles (OR 0.52, 95% CI 0.35 to 0.76, p = 0.0007; <xref ref-type="fig" rid="pone-0102477-g005">Figure 5, B</xref>). Fixed effects mode was used as there was no heterogeneity between studies (Q = 4.82, p = 0.09, I<sup>2</sup> = 58%, <xref ref-type="fig" rid="pone-0102477-g005">Figure 5, B</xref>). In addition, data of genotypic models for comparisons of E2, E3 and E4 genotypes in both dominant and recessive models were presented in <xref ref-type="table" rid="pone-0102477-t003">table 3</xref>.</p>
<fig id="pone-0102477-g005" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0102477.g005</object-id><label>Figure 5</label><caption>
<title>Forest plots of odds ratio with 95% CI for <italic>APOE</italic> polymorphism and proximal CRN (A: ε2 versus ε3, B, ε4 versus ε3) and distal CRN risk (C: ε2 versus ε3, D, ε4 versus ε3).</title>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0102477.g005" position="float" xlink:type="simple"/></fig></sec><sec id="s3f">
<title>Overall analyses on the association of <italic>APOE</italic> polymorphisms and distal CRN</title>
<p>Subgroup analysis was also performed to compare prevalence of the ε2 vs. ε3 alleles among distal CRN cases and controls. Pooled data from the available 3 studies <xref ref-type="bibr" rid="pone.0102477-Watson1">[24]</xref>, <xref ref-type="bibr" rid="pone.0102477-Kervinen1">[35]</xref>, <xref ref-type="bibr" rid="pone.0102477-Shinomiya1">[36]</xref> showed the presence of ε2 allele conferred no risk for distal CRN (OR, 1.08; 95% CI, 0.74 to 1.56; p = 0.70, <xref ref-type="fig" rid="pone-0102477-g005">Figure 5, C</xref>). The fixed-model was then used as there was no statistically significant heterogeneity between studies (Q = 1.66, p = 0.44, I<sup>2</sup> = 0%, <xref ref-type="fig" rid="pone-0102477-g005">Figure 5, C</xref>). In addition, the association of ε4 carriers vs. ε3 alleles between distal CRN cases and controls was estimated. Because there was no statistical heterogeneity between studies (Q = 3.46, p = 0.18, I<sup>2</sup> = 42%, <xref ref-type="fig" rid="pone-0102477-g005">Figure 5, D</xref>), the fixed effects mode was applied. The pooled data indicated presence of the ε4 allele indicated no decreased risk of distal CRN, in comparison with the ε3 allele (OR 1.12, 95% CI 0.89 to 1.41, p = 0.32; <xref ref-type="fig" rid="pone-0102477-g005">Figure 5, D</xref>). Additionally, genotypic analysis for comparisons of E2, E3 and E4 genotypes in both dominant and recessive models were presented in <xref ref-type="table" rid="pone-0102477-t003">table 3</xref>.</p>
</sec><sec id="s3g">
<title>Publication bias</title>
<p>We also evaluated the publication bias by testing funnel plots for obvious asymmetry. No publication bias was found from either visualization of the funnel plot or statistics of. Our data indicated there was no statistical evidence of publication bias (Egger’s, P = 0.7, Begg’s P = 0.805) (<xref ref-type="fig" rid="pone-0102477-g006">Figure 6</xref>).</p>
<fig id="pone-0102477-g006" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0102477.g006</object-id><label>Figure 6</label><caption>
<title>Funnel plot of the meta-analysis.</title>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0102477.g006" position="float" xlink:type="simple"/></fig></sec></sec><sec id="s4">
<title>Discussion</title>
<p>Eight eligible studies at last included in this meta-analysis, and 5 studies of them suggested <italic>APOE</italic> ε4 is a protective factor. In this meta-analysis, we used a total of 9243 subjects and 4310 CRN cases which including 438 patients with CRA, and 3873 patients with CRC from 8 publications to evaluate the association of <italic>APOE</italic> gene polymorphism with CRN. This meta-analysis suggested that having an <italic>APOE</italic> allele doesn’t increase the risk of CRN. Although <italic>APOE</italic> ε4 has been considered to be a protective factor in CRN <xref ref-type="bibr" rid="pone.0102477-Souza1">[25]</xref>, <xref ref-type="bibr" rid="pone.0102477-Butler1">[34]</xref>, our results indicated there was no association between a ε4 allele and CRA development.</p>
<p><italic>APOE</italic> seems to be involved in immunoregulation <xref ref-type="bibr" rid="pone.0102477-Swertfeger1">[38]</xref> and inhibiting endothelial cell proliferation <xref ref-type="bibr" rid="pone.0102477-Vogel1">[20]</xref>, which may directly affect the adenoma to carcinoma process. It was suggested that <italic>APOE</italic> may influence CRC development through three potential path ways: cholesterol and bile metabolism, triglyceride and insulin regulation, and the prolonged inflammation <xref ref-type="bibr" rid="pone.0102477-Slattery2">[37]</xref>. Due to different affinity to its receptors, <italic>APOE</italic> can influence hepatic cholesterol processing by enhancing cholesteryl ester hydrolysis <xref ref-type="bibr" rid="pone.0102477-Schwiegelshohn1">[39]</xref>, and people with the allele ε4 were found to have an increased intestinal absorption of cholesterol <xref ref-type="bibr" rid="pone.0102477-Kesaniemi1">[40]</xref> and to have a lower biliary excretion of deoxycholic acid <xref ref-type="bibr" rid="pone.0102477-Miettinen1">[41]</xref>. It was speculated <italic>APOE</italic> ε4, which is associated with more intracellular release of free than that of ε3 <xref ref-type="bibr" rid="pone.0102477-Ho1">[42]</xref> and lower concentrations of fecal bile acids in the gastrointestinal tract, has its protective role against CRC <xref ref-type="bibr" rid="pone.0102477-Kervinen1">[35]</xref>.</p>
<p>The <italic>APOE</italic> ε4 allele appears to be associated with an increased risk of gallstones and breast cancer <xref ref-type="bibr" rid="pone.0102477-Saadat1">[43]</xref>, <xref ref-type="bibr" rid="pone.0102477-Xue1">[44]</xref>. Our present data indicated that the <italic>APOE</italic> gene polymorphisms were similar between patients with CRN and controls. Our data also demonstrated <italic>APOE</italic> ε4 did not affect the overall risk for CRA, there was not a protective effect in patients with ε4 when compared to those with ε3. Despite the genetic factors has been suggested to be important for the susceptibility to CRN, other factor like racial differences may also play a role. First, genetic heterogeneity may be a reason for the conflicting results. In people of European ancestry, <italic>APOE</italic> genotype showed a positive dose-response association with LDL-C <xref ref-type="bibr" rid="pone.0102477-Khan1">[45]</xref> while study of Brazilian individuals indicated that the presence of the ε4 genotype may be a protective effect against CRC <xref ref-type="bibr" rid="pone.0102477-Souza1">[25]</xref>. In addition, the allele ε4 is much less frequent in Japanese than in Caucasians, and it was reported Finns seem to have a particularly high frequency of the allele ε4 <xref ref-type="bibr" rid="pone.0102477-Davignon2">[46]</xref>, <xref ref-type="bibr" rid="pone.0102477-Utermann1">[47]</xref>. In our meta-analysis, the included 8 studies are from Japan, Brazil, China, Australia, Finland, USA, UK, and Canada respectively on evaluating the <italic>APOE</italic> polymorphisms in relation to CRN. In addition, our data indicated the contribution of <italic>APOE</italic> polymorphisms to CRN susceptibility varies in different studies. For ethnic diversity, distinct environmental factors and eating habits characterize populations, analyze the allelic and genotypic distributions of the <italic>APOE</italic> and their association with CRA or CAC should characterize the histories and habits of people.</p>
<p>We also evaluated association of genetic variants of <italic>APOE</italic> with proximal and distal CRN. Three of the 8 included studies involving evaluated the presence of <italic>APOE</italic> polymorphisms to different parts of the colorectal tumors <xref ref-type="bibr" rid="pone.0102477-Watson1">[24]</xref>, <xref ref-type="bibr" rid="pone.0102477-Kervinen1">[35]</xref>, <xref ref-type="bibr" rid="pone.0102477-Shinomiya1">[36]</xref>. Although <italic>APOE</italic> ε4 did not affect the overall risk for CRN, there was a trend towards a protective effect in patients with right-sided cancer when compared to those with left-sided carcinoma <xref ref-type="bibr" rid="pone.0102477-Butler1">[34]</xref>, <xref ref-type="bibr" rid="pone.0102477-RobertsThomson1">[48]</xref>. However, the degree of this protection was less prominent reported by Kervinen et al. from Finland <xref ref-type="bibr" rid="pone.0102477-Kervinen1">[35]</xref>. Our meta-analysis data demonstrated, compared with those carry <italic>APOE</italic> ε3 alleles, persons with <italic>APOE</italic> ε4 genotype have significant decreased risk suffering from proximal CRN but not from distal CRN. Several reasons for the protective association between the allele ε4 of <italic>APOE</italic> and proximal colon adenomas have been reported in past years. A proposed mechanism involving in this different effect between proximal and distal CRN is the decreased levels of fecal bile acids which may result in relative lower levels of cell proliferation in the proximal colon <xref ref-type="bibr" rid="pone.0102477-Miettinen1">[41]</xref>. A potential mechanism for this effect is the low levels of fecal bile acids which may resulting in lower levels of epithelial proliferation in the proximal colon <xref ref-type="bibr" rid="pone.0102477-Miettinen1">[41]</xref>. Serum cholesterol acids are positively related to the risk of CRN <xref ref-type="bibr" rid="pone.0102477-Hill1">[49]</xref>, <xref ref-type="bibr" rid="pone.0102477-Sandler1">[50]</xref> and patients with colorectal adenomas indicated high serum deoxycholic acid levels <xref ref-type="bibr" rid="pone.0102477-Bayerdorffer2">[22]</xref>. However, in patients with the ε4 allele of <italic>APOE</italic>, the levels of biliary deoxycholic acid are relatively low <xref ref-type="bibr" rid="pone.0102477-Miettinen1">[41]</xref>, which may be associated with the low incidence of adenoma and carcinoma. This has been confirmed by the results that <italic>APOE</italic> has the ability in inhibiting endothelial proliferation <xref ref-type="bibr" rid="pone.0102477-Vogel1">[20]</xref> and <italic>APOE</italic> shows its ability in immunoregulation <xref ref-type="bibr" rid="pone.0102477-Mahley1">[51]</xref>. It seems that the alterations in luminal cholesterol delivery and fecal bile acid are involved in the protective association of the allele ε4 and proximal CRN development <xref ref-type="bibr" rid="pone.0102477-Kervinen1">[35]</xref>, <xref ref-type="bibr" rid="pone.0102477-Davidson1">[52]</xref>. <italic>APOE</italic> genotypes has been reported implicated in the breast cancer <xref ref-type="bibr" rid="pone.0102477-Chang1">[53]</xref>. <italic>APOE</italic> ε4 allele is found to be a low-penetrant risk factor for development of breast cancer <xref ref-type="bibr" rid="pone.0102477-Saadat1">[43]</xref>. The possible biological mechanisms of the association between <italic>APOE</italic> ε4 genotype and carcinoma of the proximal colon and breast is subjects carrying <italic>APOE</italic> ε4 genotype less than half of the risk of tumor cell proliferation <xref ref-type="bibr" rid="pone.0102477-Vogel1">[20]</xref>.</p>
<p>CRN incidences differ considerably between Western and non-Western countries. In recent years, a dramatic increase in CRC incidence has been reported in several Asian countries. Two studies from Asia included in our meta-analysis <xref ref-type="bibr" rid="pone.0102477-Zhongyin1">[26]</xref>, <xref ref-type="bibr" rid="pone.0102477-Shinomiya1">[36]</xref> found <italic>APOE</italic> ε4 was protective factor for CRN. Immigration studies have suggested that environmental factors rather than genetic susceptibility are primarily responsible for the secular trends of CRC incidence rates and international variability. It is more likely that the interaction of genetic susceptibility and environmental factors is the causation of colorectal carcinomas and adenomas. Therefore, not only the main effect of a gene but also the influence of gene-environment interactions on cancer risk are important from the public health perspective <xref ref-type="bibr" rid="pone.0102477-Shin1">[54]</xref>.</p>
<p>We must confess that some limitations of this study were still inherited from the published studies. First, many of the studies included in the analysis were published a decade ago, recent advance of this issue is limited. Second, selection bias may play a role in this meta-analysis. Third, due to the limited patients included in this study, it was impossible for us to perform the subgroup analysis. Last but not the least is that account of potential confounding factors which might be associated with the risk of CRN.</p>
<p>In conclusion, the pooled data showed no significant association between <italic>APOE</italic> genotype and CRN. However, compared with those carry <italic>APOE</italic> ε3 alleles, persons with <italic>APOE</italic> ε4 genotype have significant decreased risk suffering from proximal CRN but not from distal CRN. Due to the small number of studies addressing the association of <italic>APOE</italic> polymorphisms and CRN, the conclusion whether <italic>APOE</italic> ε4 and ε2 increase or decrease the susceptibility to CRN requires further investigation. The mechanism of the involvement of <italic>APOE</italic> in carcinogenesis is still not clear and further studies with larger samples are necessary to confirm this in population.</p>
</sec><sec id="s5">
<title>Supporting Information</title>
<supplementary-material id="pone.0102477.s001" mimetype="application/msword" xlink:href="info:doi/10.1371/journal.pone.0102477.s001" position="float" xlink:type="simple"><label>Checklist S1</label><caption>
<p>PRISMA Checklist.</p>
<p>(DOC)</p>
</caption></supplementary-material></sec></body>
<back><ref-list>
<title>References</title>
<ref id="pone.0102477-Anderson1"><label>1</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Anderson</surname><given-names>WF</given-names></name>, <name name-style="western"><surname>Guyton</surname><given-names>KZ</given-names></name>, <name name-style="western"><surname>Hiatt</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>Vernon</surname><given-names>SW</given-names></name>, <name name-style="western"><surname>Levin</surname><given-names>B</given-names></name>, <etal>et al</etal>. (<year>2002</year>) <article-title>Colorectal cancer screening for persons at average risk</article-title>. <source>J Natl Cancer Inst</source> <volume>94</volume>: <fpage>1126</fpage>–<lpage>1133</lpage>.</mixed-citation>
</ref>
<ref id="pone.0102477-Muto1"><label>2</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Muto</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Bussey</surname><given-names>HJ</given-names></name>, <name name-style="western"><surname>Morson</surname><given-names>BC</given-names></name> (<year>1975</year>) <article-title>The evolution of cancer of the colon and rectum</article-title>. <source>Cancer</source> <volume>36</volume>: <fpage>2251</fpage>–<lpage>2270</lpage>.</mixed-citation>
</ref>
<ref id="pone.0102477-Stryker1"><label>3</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Stryker</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>Wolff</surname><given-names>BG</given-names></name>, <name name-style="western"><surname>Culp</surname><given-names>CE</given-names></name>, <name name-style="western"><surname>Libbe</surname><given-names>SD</given-names></name>, <name name-style="western"><surname>Ilstrup</surname><given-names>DM</given-names></name>, <etal>et al</etal>. (<year>1987</year>) <article-title>Natural history of untreated colonic polyps</article-title>. <source>Gastroenterology</source> <volume>93</volume>: <fpage>1009</fpage>–<lpage>1013</lpage>.</mixed-citation>
</ref>
<ref id="pone.0102477-Fearon1"><label>4</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fearon</surname><given-names>ER</given-names></name>, <name name-style="western"><surname>Vogelstein</surname><given-names>B</given-names></name> (<year>1990</year>) <article-title>A genetic model for colorectal tumorigenesis</article-title>. <source>Cell</source> <volume>61</volume>: <fpage>759</fpage>–<lpage>767</lpage>.</mixed-citation>
</ref>
<ref id="pone.0102477-Ferlay1"><label>5</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ferlay</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Shin</surname><given-names>HR</given-names></name>, <name name-style="western"><surname>Bray</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Forman</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Mathers</surname><given-names>C</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008</article-title>. <source>Int J Cancer</source> <volume>127</volume>: <fpage>2893</fpage>–<lpage>2917</lpage>.</mixed-citation>
</ref>
<ref id="pone.0102477-Mrkonjic1"><label>6</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mrkonjic</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Chappell</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Pethe</surname><given-names>VV</given-names></name>, <name name-style="western"><surname>Manno</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Daftary</surname><given-names>D</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Association of apolipoprotein E polymorphisms and dietary factors in colorectal cancer</article-title>. <source>Br J Cancer</source> <volume>100</volume>: <fpage>1966</fpage>–<lpage>1974</lpage>.</mixed-citation>
</ref>
<ref id="pone.0102477-Rall1"><label>7</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rall</surname><given-names>SC</given-names><suffix>Jr</suffix></name>, <name name-style="western"><surname>Weisgraber</surname><given-names>KH</given-names></name>, <name name-style="western"><surname>Mahley</surname><given-names>RW</given-names></name> (<year>1982</year>) <article-title>Human apolipoprotein E. The complete amino acid sequence</article-title>. <source>J Biol Chem</source> <volume>257</volume>: <fpage>4171</fpage>–<lpage>4178</lpage>.</mixed-citation>
</ref>
<ref id="pone.0102477-Weisgraber1"><label>8</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Weisgraber</surname><given-names>KH</given-names></name>, <name name-style="western"><surname>Rall</surname><given-names>SC</given-names><suffix>Jr</suffix></name>, <name name-style="western"><surname>Mahley</surname><given-names>RW</given-names></name> (<year>1981</year>) <article-title>Human E apoprotein heterogeneity. Cysteine-arginine interchanges in the amino acid sequence of the apo-E isoforms</article-title>. <source>J Biol Chem</source> <volume>256</volume>: <fpage>9077</fpage>–<lpage>9083</lpage>.</mixed-citation>
</ref>
<ref id="pone.0102477-Ganan1"><label>9</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ganan</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Corella</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Guillen</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Ordovas</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Pocovi</surname><given-names>M</given-names></name> (<year>2004</year>) <article-title>Frequencies of apolipoprotein A4 gene polymorphisms and association with serum lipid concentrations in two healthy Spanish populations</article-title>. <source>Hum Biol</source> <volume>76</volume>: <fpage>253</fpage>–<lpage>266</lpage>.</mixed-citation>
</ref>
<ref id="pone.0102477-Song1"><label>10</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Song</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Stampfer</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>S</given-names></name> (<year>2004</year>) <article-title>Meta-analysis: apolipoprotein E genotypes and risk for coronary heart disease</article-title>. <source>Ann Intern Med</source> <volume>141</volume>: <fpage>137</fpage>–<lpage>147</lpage>.</mixed-citation>
</ref>
<ref id="pone.0102477-JofreMonseny1"><label>11</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jofre-Monseny</surname><given-names>L</given-names></name>, <name name-style="western"><surname>de Pascual-Teresa</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Plonka</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Huebbe</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Boesch-Saadatmandi</surname><given-names>C</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>Differential effects of apolipoprotein E3 and E4 on markers of oxidative status in macrophages</article-title>. <source>Br J Nutr</source> <volume>97</volume>: <fpage>864</fpage>–<lpage>871</lpage>.</mixed-citation>
</ref>
<ref id="pone.0102477-Davignon1"><label>12</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Davignon</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Gregg</surname><given-names>RE</given-names></name>, <name name-style="western"><surname>Sing</surname><given-names>CF</given-names></name> (<year>1988</year>) <article-title>Apolipoprotein E polymorphism and atherosclerosis</article-title>. <source>Arteriosclerosis</source> <volume>8</volume>: <fpage>1</fpage>–<lpage>21</lpage>.</mixed-citation>
</ref>
<ref id="pone.0102477-Xhignesse1"><label>13</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Xhignesse</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Lussier-Cacan</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Sing</surname><given-names>CF</given-names></name>, <name name-style="western"><surname>Kessling</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Davignon</surname><given-names>J</given-names></name> (<year>1991</year>) <article-title>Influences of common variants of apolipoprotein E on measures of lipid metabolism in a sample selected for health</article-title>. <source>Arterioscler Thromb</source> <volume>11</volume>: <fpage>1100</fpage>–<lpage>1110</lpage>.</mixed-citation>
</ref>
<ref id="pone.0102477-Bretsky1"><label>14</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bretsky</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Guralnik</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Launer</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Albert</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Seeman</surname><given-names>TE</given-names></name> (<year>2003</year>) <article-title>The role of APOE-epsilon4 in longitudinal cognitive decline: MacArthur Studies of Successful Aging</article-title>. <source>Neurology</source> <volume>60</volume>: <fpage>1077</fpage>–<lpage>1081</lpage>.</mixed-citation>
</ref>
<ref id="pone.0102477-Corder1"><label>15</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Corder</surname><given-names>EH</given-names></name>, <name name-style="western"><surname>Saunders</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Strittmatter</surname><given-names>WJ</given-names></name>, <name name-style="western"><surname>Schmechel</surname><given-names>DE</given-names></name>, <name name-style="western"><surname>Gaskell</surname><given-names>PC</given-names></name>, <etal>et al</etal>. (<year>1993</year>) <article-title>Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families</article-title>. <source>Science</source> <volume>261</volume>: <fpage>921</fpage>–<lpage>923</lpage>.</mixed-citation>
</ref>
<ref id="pone.0102477-Wilson1"><label>16</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wilson</surname><given-names>PW</given-names></name>, <name name-style="western"><surname>Schaefer</surname><given-names>EJ</given-names></name>, <name name-style="western"><surname>Larson</surname><given-names>MG</given-names></name>, <name name-style="western"><surname>Ordovas</surname><given-names>JM</given-names></name> (<year>1996</year>) <article-title>Apolipoprotein E alleles and risk of coronary disease. A meta-analysis</article-title>. <source>Arterioscler Thromb Vasc Biol</source> <volume>16</volume>: <fpage>1250</fpage>–<lpage>1255</lpage>.</mixed-citation>
</ref>
<ref id="pone.0102477-CedazoMinguez1"><label>17</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cedazo-Minguez</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Popescu</surname><given-names>BO</given-names></name>, <name name-style="western"><surname>Blanco-Millan</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Akterin</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Pei</surname><given-names>JJ</given-names></name>, <etal>et al</etal>. (<year>2003</year>) <article-title>Apolipoprotein E and beta-amyloid (1–42) regulation of glycogen synthase kinase-3beta</article-title>. <source>J Neurochem</source> <volume>87</volume>: <fpage>1152</fpage>–<lpage>1164</lpage>.</mixed-citation>
</ref>
<ref id="pone.0102477-Grocott1"><label>18</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Grocott</surname><given-names>HP</given-names></name>, <name name-style="western"><surname>Newman</surname><given-names>MF</given-names></name>, <name name-style="western"><surname>El-Moalem</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Bainbridge</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Butler</surname><given-names>A</given-names></name>, <etal>et al</etal>. (<year>2001</year>) <article-title>Apolipoprotein E genotype differentially influences the proinflammatory and anti-inflammatory response to cardiopulmonary bypass</article-title>. <source>J Thorac Cardiovasc Surg</source> <volume>122</volume>: <fpage>622</fpage>–<lpage>623</lpage>.</mixed-citation>
</ref>
<ref id="pone.0102477-Niemi1"><label>19</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Niemi</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Hakkinen</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Karttunen</surname><given-names>TJ</given-names></name>, <name name-style="western"><surname>Eskelinen</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Kervinen</surname><given-names>K</given-names></name>, <etal>et al</etal>. (<year>2002</year>) <article-title>Apolipoprotein E and colon cancer. Expression in normal and malignant human intestine and effect on cultured human colonic adenocarcinoma cells</article-title>. <source>Eur J Intern Med</source> <volume>13</volume>: <fpage>37</fpage>–<lpage>43</lpage>.</mixed-citation>
</ref>
<ref id="pone.0102477-Vogel1"><label>20</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Vogel</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Guo</surname><given-names>NH</given-names></name>, <name name-style="western"><surname>Guy</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Drezlich</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Krutzsch</surname><given-names>HC</given-names></name>, <etal>et al</etal>. (<year>1994</year>) <article-title>Apolipoprotein E: a potent inhibitor of endothelial and tumor cell proliferation</article-title>. <source>J Cell Biochem</source> <volume>54</volume>: <fpage>299</fpage>–<lpage>308</lpage>.</mixed-citation>
</ref>
<ref id="pone.0102477-Bayerdorffer1"><label>21</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bayerdorffer</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Mannes</surname><given-names>GA</given-names></name>, <name name-style="western"><surname>Ochsenkuhn</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Dirschedl</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Wiebecke</surname><given-names>B</given-names></name>, <etal>et al</etal>. (<year>1995</year>) <article-title>Unconjugated secondary bile acids in the serum of patients with colorectal adenomas</article-title>. <source>Gut</source> <volume>36</volume>: <fpage>268</fpage>–<lpage>273</lpage>.</mixed-citation>
</ref>
<ref id="pone.0102477-Bayerdorffer2"><label>22</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bayerdorffer</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Mannes</surname><given-names>GA</given-names></name>, <name name-style="western"><surname>Richter</surname><given-names>WO</given-names></name>, <name name-style="western"><surname>Ochsenkuhn</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Wiebecke</surname><given-names>B</given-names></name>, <etal>et al</etal>. (<year>1993</year>) <article-title>Increased serum deoxycholic acid levels in men with colorectal adenomas</article-title>. <source>Gastroenterology</source> <volume>104</volume>: <fpage>145</fpage>–<lpage>151</lpage>.</mixed-citation>
</ref>
<ref id="pone.0102477-Reddy1"><label>23</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Reddy</surname><given-names>BS</given-names></name>, <name name-style="western"><surname>Wynder</surname><given-names>EL</given-names></name> (<year>1973</year>) <article-title>Large-bowel carcinogenesis: fecal constituents of populations with diverse incidence rates of colon cancer</article-title>. <source>J Natl Cancer Inst</source> <volume>50</volume>: <fpage>1437</fpage>–<lpage>1442</lpage>.</mixed-citation>
</ref>
<ref id="pone.0102477-Watson1"><label>24</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Watson</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Gay</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Stebbings</surname><given-names>WS</given-names></name>, <name name-style="western"><surname>Speakman</surname><given-names>CT</given-names></name>, <name name-style="western"><surname>Bingham</surname><given-names>SA</given-names></name>, <etal>et al</etal>. (<year>2003</year>) <article-title>Apolipoprotein E gene polymorphism and colorectal cancer: gender-specific modulation of risk and prognosis</article-title>. <source>Clin Sci (Lond)</source> <volume>104</volume>: <fpage>537</fpage>–<lpage>545</lpage>.</mixed-citation>
</ref>
<ref id="pone.0102477-Souza1"><label>25</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Souza</surname><given-names>DR</given-names></name>, <name name-style="western"><surname>Nakazone</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Pinhel</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Alvares</surname><given-names>RM</given-names></name>, <name name-style="western"><surname>Monaco</surname><given-names>AC</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Association between apolipoprotein E genotype, serum lipids, and colorectal cancer in Brazilian individuals</article-title>. <source>Braz J Med Biol Res</source> <volume>42</volume>: <fpage>397</fpage>–<lpage>403</lpage>.</mixed-citation>
</ref>
<ref id="pone.0102477-Zhongyin1"><label>26</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhongyin</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Hesheng</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Jun</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Jihong</surname><given-names>C</given-names></name> (<year>2006</year>) <article-title>Association of serum lipids and apolipoprotein E gene polymorphism with the risk of colorectal adenomas</article-title>. <source>Saudi Med J</source> <volume>27</volume>: <fpage>161</fpage>–<lpage>164</lpage>.</mixed-citation>
</ref>
<ref id="pone.0102477-Slattery1"><label>27</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Slattery</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Murtaugh</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Sweeney</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Ma</surname><given-names>KN</given-names></name>, <name name-style="western"><surname>Potter</surname><given-names>JD</given-names></name>, <etal>et al</etal>. (<year>2005</year>) <article-title>PPARgamma, energy balance, and associations with colon and rectal cancer</article-title>. <source>Nutr Cancer</source> <volume>51</volume>: <fpage>155</fpage>–<lpage>161</lpage>.</mixed-citation>
</ref>
<ref id="pone.0102477-Moher1"><label>28</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Moher</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Cook</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Eastwood</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Olkin</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Rennie</surname><given-names>D</given-names></name>, <etal>et al</etal>. (<year>1999</year>) <article-title>Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses</article-title>. <source>Lancet</source> <volume>354</volume>: <fpage>1896</fpage>–<lpage>1900</lpage>.</mixed-citation>
</ref>
<ref id="pone.0102477-Higgins1"><label>29</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Higgins</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Thompson</surname><given-names>SG</given-names></name>, <name name-style="western"><surname>Deeks</surname><given-names>JJ</given-names></name>, <name name-style="western"><surname>Altman</surname><given-names>DG</given-names></name> (<year>2003</year>) <article-title>Measuring inconsistency in meta-analyses</article-title>. <source>BMJ</source> <volume>327</volume>: <fpage>557</fpage>–<lpage>560</lpage>.</mixed-citation>
</ref>
<ref id="pone.0102477-Cohn1"><label>30</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cohn</surname><given-names>LD</given-names></name>, <name name-style="western"><surname>Becker</surname><given-names>BJ</given-names></name> (<year>2003</year>) <article-title>How meta-analysis increases statistical power</article-title>. <source>Psychol Methods</source> <volume>8</volume>: <fpage>243</fpage>–<lpage>253</lpage>.</mixed-citation>
</ref>
<ref id="pone.0102477-DerSimonian1"><label>31</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>DerSimonian</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Laird</surname><given-names>N</given-names></name> (<year>1986</year>) <article-title>Meta-analysis in clinical trials</article-title>. <source>Control Clin Trials</source> <volume>7</volume>: <fpage>177</fpage>–<lpage>188</lpage>.</mixed-citation>
</ref>
<ref id="pone.0102477-Begg1"><label>32</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Begg</surname><given-names>CB</given-names></name>, <name name-style="western"><surname>Mazumdar</surname><given-names>M</given-names></name> (<year>1994</year>) <article-title>Operating characteristics of a rank correlation test for publication bias</article-title>. <source>Biometrics</source> <volume>50</volume>: <fpage>1088</fpage>–<lpage>1101</lpage>.</mixed-citation>
</ref>
<ref id="pone.0102477-Egger1"><label>33</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Egger</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Davey Smith</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Schneider</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Minder</surname><given-names>C</given-names></name> (<year>1997</year>) <article-title>Bias in meta-analysis detected by a simple, graphical test</article-title>. <source>BMJ</source> <volume>315</volume>: <fpage>629</fpage>–<lpage>634</lpage>.</mixed-citation>
</ref>
<ref id="pone.0102477-Butler1"><label>34</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Butler</surname><given-names>WJ</given-names></name>, <name name-style="western"><surname>Ryan</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Roberts-Thomson</surname><given-names>IC</given-names></name> (<year>2001</year>) <article-title>Metabolic genotypes and risk for colorectal cancer</article-title>. <source>J Gastroenterol Hepatol</source> <volume>16</volume>: <fpage>631</fpage>–<lpage>635</lpage>.</mixed-citation>
</ref>
<ref id="pone.0102477-Kervinen1"><label>35</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kervinen</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Sodervik</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Makela</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Lehtola</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Niemi</surname><given-names>M</given-names></name>, <etal>et al</etal>. (<year>1996</year>) <article-title>Is the development of adenoma and carcinoma in proximal colon related to apolipoprotein E phenotype?</article-title> <source>Gastroenterology</source> <volume>110</volume>: <fpage>1785</fpage>–<lpage>1790</lpage>.</mixed-citation>
</ref>
<ref id="pone.0102477-Shinomiya1"><label>36</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Shinomiya</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Sasaki</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Kiyohara</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Tsuji</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Inoue</surname><given-names>H</given-names></name>, <etal>et al</etal>. (<year>2001</year>) <article-title>Apolipoprotein E genotype, serum lipids, and colorectal adenomas in Japanese men</article-title>. <source>Cancer Lett</source> <volume>164</volume>: <fpage>33</fpage>–<lpage>40</lpage>.</mixed-citation>
</ref>
<ref id="pone.0102477-Slattery2"><label>37</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Slattery</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Sweeney</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Murtaugh</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Ma</surname><given-names>KN</given-names></name>, <name name-style="western"><surname>Potter</surname><given-names>JD</given-names></name>, <etal>et al</etal>. (<year>2005</year>) <article-title>Associations between apoE genotype and colon and rectal cancer</article-title>. <source>Carcinogenesis</source> <volume>26</volume>: <fpage>1422</fpage>–<lpage>1429</lpage>.</mixed-citation>
</ref>
<ref id="pone.0102477-Swertfeger1"><label>38</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Swertfeger</surname><given-names>DK</given-names></name>, <name name-style="western"><surname>Hui</surname><given-names>DY</given-names></name> (<year>2001</year>) <article-title>Apolipoprotein E: a cholesterol transport protein with lipid transport-independent cell signaling properties</article-title>. <source>Front Biosci</source> <volume>6</volume>: <fpage>D526</fpage>–<lpage>535</lpage>.</mixed-citation>
</ref>
<ref id="pone.0102477-Schwiegelshohn1"><label>39</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Schwiegelshohn</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Presley</surname><given-names>JF</given-names></name>, <name name-style="western"><surname>Gorecki</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Vogel</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Carpentier</surname><given-names>YA</given-names></name>, <etal>et al</etal>. (<year>1995</year>) <article-title>Effects of apoprotein E on intracellular metabolism of model triglyceride-rich particles are distinct from effects on cell particle uptake</article-title>. <source>J Biol Chem</source> <volume>270</volume>: <fpage>1761</fpage>–<lpage>1769</lpage>.</mixed-citation>
</ref>
<ref id="pone.0102477-Kesaniemi1"><label>40</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kesaniemi</surname><given-names>YA</given-names></name>, <name name-style="western"><surname>Ehnholm</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Miettinen</surname><given-names>TA</given-names></name> (<year>1987</year>) <article-title>Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype</article-title>. <source>J Clin Invest</source> <volume>80</volume>: <fpage>578</fpage>–<lpage>581</lpage>.</mixed-citation>
</ref>
<ref id="pone.0102477-Miettinen1"><label>41</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Miettinen</surname><given-names>TA</given-names></name> (<year>1991</year>) <article-title>Impact of apo E phenotype on the regulation of cholesterol metabolism</article-title>. <source>Ann Med</source> <volume>23</volume>: <fpage>181</fpage>–<lpage>186</lpage>.</mixed-citation>
</ref>
<ref id="pone.0102477-Ho1"><label>42</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ho</surname><given-names>YY</given-names></name>, <name name-style="western"><surname>Al-Haideri</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Mazzone</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Vogel</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Presley</surname><given-names>JF</given-names></name>, <etal>et al</etal>. (<year>2000</year>) <article-title>Endogenously expressed apolipoprotein E has different effects on cell lipid metabolism as compared to exogenous apolipoprotein E carried on triglyceride-rich particles</article-title>. <source>Biochemistry</source> <volume>39</volume>: <fpage>4746</fpage>–<lpage>4754</lpage>.</mixed-citation>
</ref>
<ref id="pone.0102477-Saadat1"><label>43</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Saadat</surname><given-names>M</given-names></name> (<year>2012</year>) <article-title>Apolipoprotein E (APOE) Polymorphisms and Susceptibility to Breast Cancer: A Meta-Analysis</article-title>. <source>Cancer Res Treat</source> <volume>44</volume>: <fpage>121</fpage>–<lpage>126</lpage>.</mixed-citation>
</ref>
<ref id="pone.0102477-Xue1"><label>44</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Xue</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Niu</surname><given-names>WQ</given-names></name>, <name name-style="western"><surname>Jiang</surname><given-names>ZY</given-names></name>, <name name-style="western"><surname>Zheng</surname><given-names>MH</given-names></name>, <name name-style="western"><surname>Fei</surname><given-names>J</given-names></name> (<year>2012</year>) <article-title>A meta-analysis of apolipoprotein E gene epsilon2/epsilon3/epsilon4 polymorphism for gallbladder stone disease</article-title>. <source>PLoS One</source> <volume>7</volume>: <fpage>e45849</fpage>.</mixed-citation>
</ref>
<ref id="pone.0102477-Khan1"><label>45</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Khan</surname><given-names>TA</given-names></name>, <name name-style="western"><surname>Shah</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Prieto</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Price</surname><given-names>J</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>Apolipoprotein E genotype, cardiovascular biomarkers and risk of stroke: systematic review and meta-analysis of 14,015 stroke cases and pooled analysis of primary biomarker data from up to 60,883 individuals</article-title>. <source>Int J Epidemiol</source> <volume>42</volume>: <fpage>475</fpage>–<lpage>492</lpage>.</mixed-citation>
</ref>
<ref id="pone.0102477-Davignon2"><label>46</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Davignon</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Bouthillier</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Nestruck</surname><given-names>AC</given-names></name>, <name name-style="western"><surname>Sing</surname><given-names>CF</given-names></name> (<year>1988</year>) <article-title>Apolipoprotein E polymorphism and atherosclerosis: insight from a study in octogenarians</article-title>. <source>Trans Am Clin Climatol Assoc</source> <volume>99</volume>: <fpage>100</fpage>–<lpage>110</lpage>.</mixed-citation>
</ref>
<ref id="pone.0102477-Utermann1"><label>47</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Utermann</surname><given-names>G</given-names></name> (<year>1987</year>) <article-title>Apolipoprotein E polymorphism in health and disease</article-title>. <source>Am Heart J</source> <volume>113</volume>: <fpage>433</fpage>–<lpage>440</lpage>.</mixed-citation>
</ref>
<ref id="pone.0102477-RobertsThomson1"><label>48</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Roberts-Thomson</surname><given-names>IC</given-names></name>, <name name-style="western"><surname>Butler</surname><given-names>WJ</given-names></name>, <name name-style="western"><surname>Ryan</surname><given-names>P</given-names></name> (<year>1999</year>) <article-title>Meat, metabolic genotypes and risk for colorectal cancer</article-title>. <source>Eur J Cancer Prev</source> <volume>8</volume>: <fpage>207</fpage>–<lpage>211</lpage>.</mixed-citation>
</ref>
<ref id="pone.0102477-Hill1"><label>49</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hill</surname><given-names>MJ</given-names></name> (<year>1989</year>) <article-title>Aetiology of colorectal cancer: current concepts</article-title>. <source>Baillieres Clin Gastroenterol</source> <volume>3</volume>: <fpage>567</fpage>–<lpage>592</lpage>.</mixed-citation>
</ref>
<ref id="pone.0102477-Sandler1"><label>50</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sandler</surname><given-names>RS</given-names></name>, <name name-style="western"><surname>Lyles</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Peipins</surname><given-names>LA</given-names></name>, <name name-style="western"><surname>McAuliffe</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Woosley</surname><given-names>JT</given-names></name>, <etal>et al</etal>. (<year>1993</year>) <article-title>Diet and risk of colorectal adenomas: macronutrients, cholesterol, and fiber</article-title>. <source>J Natl Cancer Inst</source> <volume>85</volume>: <fpage>884</fpage>–<lpage>891</lpage>.</mixed-citation>
</ref>
<ref id="pone.0102477-Mahley1"><label>51</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mahley</surname><given-names>RW</given-names></name> (<year>1988</year>) <article-title>Apolipoprotein E: cholesterol transport protein with expanding role in cell biology</article-title>. <source>Science</source> <volume>240</volume>: <fpage>622</fpage>–<lpage>630</lpage>.</mixed-citation>
</ref>
<ref id="pone.0102477-Davidson1"><label>52</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Davidson</surname><given-names>NO</given-names></name> (<year>1996</year>) <article-title>Apolipoprotein E polymorphism: another player in the genetics of colon cancer susceptibility?</article-title> <source>Gastroenterology</source> <volume>110</volume>: <fpage>2006</fpage>–<lpage>2009</lpage>.</mixed-citation>
</ref>
<ref id="pone.0102477-Chang1"><label>53</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chang</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>Hou</surname><given-names>MF</given-names></name>, <name name-style="western"><surname>Tsai</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Kao</surname><given-names>JT</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>SH</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>Association between the apolipoprotein E genotypes and breast cancer patients in Taiwanese</article-title>. <source>Breast Cancer Res Treat</source> <volume>98</volume>: <fpage>109</fpage>–<lpage>113</lpage>.</mixed-citation>
</ref>
<ref id="pone.0102477-Shin1"><label>54</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Shin</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>J</given-names></name> (<year>2010</year>) <article-title>Effect modification of meat intake by genetic polymorphisms on colorectal neoplasia susceptibility</article-title>. <source>Asian Pac J Cancer Prev</source> <volume>11</volume>: <fpage>281</fpage>–<lpage>287</lpage>.</mixed-citation>
</ref>
</ref-list></back>
</article>